Key result
Robot-assisted minimally invasive mitral valve repair shows feasibility in a phase I trial patient.
Reports a case of robot-assisted minimally invasive mitral valve repair in the United States under an FDA-guided phase I clinical trial.
Supports feasibility under FDA phase I oversight; leaves open need for larger trials on safety and efficacy.
A case of a robot-assisted cardiac operation in the United States is reported. Minimally invasive mitral valve repair was assisted with a surgical robot under a Food and Drug Administration–guided phase I clinical trial.
No takes yet. Share an insight, caveat, or question.
Grossi et al. (2000) studied this question. Robot-assisted minimally invasive mitral valve repair was successfully performed in a patient under an FDA-guided phase I clinical trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: